Simplify Asset Management Inc.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1846368
Las Vegas, NV
Position in NBIX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$330,008
-$152,781 QoQ
Shares Held
2,505
-26.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Simplify Asset Management Inc. holds $23,068,557 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
34,251 | $20,310,157 | |
| 2 | PCRX |
Pacira BioSciences, Inc.
|
62,653 | $1,415,957 | |
| 3 | AQST |
Aquestive Therapeutics, Inc.
|
234,279 | $972,257 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
2,505 | $330,008 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
11,447 | $40,178 |
All Filings in NBIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $330,008 | 2,505 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $482,789 | 3,404 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,141,277 | 36,624 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $5,844,207 | 46,497 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,242,304 | 20,274 | Shares | Sole | 2025-05-13 | |
| 2024-06-30 | $3,143,556 | 22,834 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||